Log in
NASDAQ:DOX

Amdocs Stock Forecast, Price & News

$66.73
+0.79 (+1.20 %)
(As of 11/27/2020 12:00 AM ET)
Add
Compare
Today's Range
$65.77
Now: $66.73
$67.01
50-Day Range
$54.96
MA: $59.98
$66.89
52-Week Range
$44.05
Now: $66.73
$77.29
Volume319,741 shs
Average Volume863,326 shs
Market Capitalization$8.99 billion
P/E Ratio18.04
Dividend Yield1.99%
Beta0.67
Amdocs Limited, through its subsidiaries, provides software and services to the communications, cable and satellite, entertainment, media industry, and other service providers worldwide. The company offers amdocsONE, a line of services, including offer end-to-end systems integration, managed, testing, data and intelligence, cloud, digital business operations, and consulting services that address various service provider business imperatives, including consumer experience and monetization, media and digital services, enterprise and connected society, open cloud networks, new domains and disruptions, and services and hybrid operations. In addition, the company offers revenue guard services designed to detect and resolve revenue leakage, fraud, and cyber fraud; and the BriteBill, a multi-channel bill presentment platform. Further, it provides advertising and media services for media publishers, TV networks, video streaming providers, advertising agencies, and service providers; and application-to-person text messaging solutions. The company was incorporated in 1988 and is headquartered in Chesterfield, Missouri.
Read More
Amdocs logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 2.9Dividend Strength: 2.5Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.26 out of 5 stars


Industry, Sector and Symbol

Industry Custom computer programming services
Sub-IndustryIT Consulting & Other Services
Current SymbolNASDAQ:DOX
CUSIPG0260210
Phone1 314 212 7000
Employees26,000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.17 billion
Cash Flow$5.84 per share
Book Value$27.19 per share

Profitability

Net Income$497.84 million

Miscellaneous

Market Cap$8.99 billion
Next Earnings Date2/2/2021 (Estimated)
OptionableOptionable
$66.73
+0.79 (+1.20 %)
(As of 11/27/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive DOX News and Ratings via Email

Sign-up to receive the latest news and ratings for DOX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Amdocs (NASDAQ:DOX) Frequently Asked Questions

How has Amdocs' stock been impacted by COVID-19 (Coronavirus)?

Amdocs' stock was trading at $61.42 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, DOX shares have increased by 8.6% and is now trading at $66.73.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Amdocs?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amdocs in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Amdocs
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Amdocs?

Wall Street analysts have given Amdocs a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Amdocs wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Amdocs' next earnings date?

Amdocs is scheduled to release its next quarterly earnings announcement on Tuesday, February 2nd 2021.
View our earnings forecast for Amdocs
.

How were Amdocs' earnings last quarter?

Amdocs Limited (NASDAQ:DOX) posted its earnings results on Tuesday, November, 10th. The technology company reported $1.23 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $1.19 by $0.04. The technology company had revenue of $1.05 billion for the quarter, compared to analysts' expectations of $1.03 billion. Amdocs had a net margin of 11.94% and a return on equity of 15.57%. Amdocs's revenue for the quarter was up 2.2% on a year-over-year basis. During the same period in the prior year, the firm posted $1.08 earnings per share.
View Amdocs' earnings history
.

How often does Amdocs pay dividends? What is the dividend yield for Amdocs?

Amdocs announced a quarterly dividend on Tuesday, November 10th. Shareholders of record on Thursday, December 31st will be paid a dividend of $0.327 per share on Friday, January 22nd. This represents a $1.31 annualized dividend and a yield of 1.96%. The ex-dividend date of this dividend is Wednesday, December 30th.
View Amdocs' dividend history
.

What guidance has Amdocs issued on next quarter's earnings?

Amdocs issued an update on its first quarter earnings guidance on Tuesday, November, 10th. The company provided earnings per share guidance of $1.09-1.15 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.14. The company issued revenue guidance of $1.055-1.095 billion, compared to the consensus revenue estimate of $1.06 billion.

What price target have analysts set for DOX?

4 Wall Street analysts have issued 12 month price objectives for Amdocs' shares. Their forecasts range from $74.00 to $76.00. On average, they expect Amdocs' share price to reach $75.00 in the next year. This suggests a possible upside of 12.4% from the stock's current price.
View analysts' price targets for Amdocs
.

Are investors shorting Amdocs?

Amdocs saw a increase in short interest during the month of October. As of October 15th, there was short interest totaling 2,580,000 shares, an increase of 14.7% from the September 30th total of 2,250,000 shares. Based on an average daily trading volume, of 629,800 shares, the days-to-cover ratio is presently 4.1 days. Currently, 1.9% of the company's stock are short sold.
View Amdocs' Short Interest
.

Who are some of Amdocs' key competitors?

What other stocks do shareholders of Amdocs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Amdocs investors own include The Home Depot (HD), Pfizer (PFE), AT&T (T), NVIDIA (NVDA), Exxon Mobil (XOM), AbbVie (ABBV), International Business Machines (IBM), Johnson & Johnson (JNJ), Advanced Micro Devices (AMD) and Comcast (CMCSA).

Who are Amdocs' key executives?

Amdocs' management team includes the following people:
  • Mr. Joshua Sheffer, Pres, CEO & Director (Age 60)
  • Ms. Tamar Rapaport-Dagim, CFO & COO (Age 49)
  • Mr. Matthew E. Smith, Sec. & Head of Investor Relations (Age 48)
  • Mr. Gary Miles, Chief Marketing Officer
  • Darcy Antonellis, Head of Amdocs Media
  • Mr. Oren Marmur, Head of NFV - Amdocs Open Network
  • Mr. Rajat Raheja, Division Pres of Amdocs Devel. Center India Pvt. Ltd (Age 51)
  • Anthony Goonetilleke, Group Pres of Media, Network & Technology

What is Amdocs' stock symbol?

Amdocs trades on the NASDAQ under the ticker symbol "DOX."

Who are Amdocs' major shareholders?

Amdocs' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include LSV Asset Management (4.74%), Wells Fargo & Company MN (4.08%), Massachusetts Financial Services Co. MA (3.82%), BlackRock Inc. (2.86%), Cooke & Bieler LP (1.70%) and Acadian Asset Management LLC (1.63%).

Which institutional investors are selling Amdocs stock?

DOX stock was sold by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC, Wells Fargo & Company MN, Lord Abbett & CO. LLC, AQR Capital Management LLC, New York State Common Retirement Fund, Arrowstreet Capital Limited Partnership, Acadian Asset Management LLC, and Charles Schwab Investment Management Inc..

Which institutional investors are buying Amdocs stock?

DOX stock was purchased by a variety of institutional investors in the last quarter, including LSV Asset Management, Massachusetts Financial Services Co. MA, Truist Financial Corp, First Trust Advisors LP, AXA S.A., Cooke & Bieler LP, Voloridge Investment Management LLC, and Crossmark Global Holdings Inc..

How do I buy shares of Amdocs?

Shares of DOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Amdocs' stock price today?

One share of DOX stock can currently be purchased for approximately $66.73.

How big of a company is Amdocs?

Amdocs has a market capitalization of $8.99 billion and generates $4.17 billion in revenue each year. The technology company earns $497.84 million in net income (profit) each year or $4.19 on an earnings per share basis. Amdocs employs 26,000 workers across the globe.

What is Amdocs' official website?

The official website for Amdocs is www.amdocs.com.

How can I contact Amdocs?

Amdocs' mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The technology company can be reached via phone at 1 314 212 7000 or via email at [email protected]

This page was last updated on 11/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.